OptiNose (NSDQ:OPTN) raised $120 million with its initial public offering last week, adding $20 million to the target is set earlier this month.
Yardley, Penn.-based OptiNose floated 7.5 million shares at $16 apiece in the offering, above the range it set Oct. 3 for 6.3 million shares at $15 to $17 apiece.
Get the full story at our sister site, Drug Delivery Business News.
The post OptiNose IPO pulls in $120m appeared first on MassDevice.
from MassDevice http://ift.tt/2ysQI8K
Cap comentari:
Publica un comentari a l'entrada